Update on MDR Tuberculosis
Unknown Author
Sold by Ria Christie Collections, Uxbridge, United Kingdom
AbeBooks Seller since 25 March 2015
New - Soft cover
Condition: New
Ships from United Kingdom to U.S.A.
Quantity: 2 available
Add to basketSold by Ria Christie Collections, Uxbridge, United Kingdom
AbeBooks Seller since 25 March 2015
Condition: New
Quantity: 2 available
Add to basketSection 1: General
1. Impact of Higher Prevalence in Countries with Evolving Healthcare Systems and High Multidrug-resistant Tuberculosis Burden
2. How Multidrug-resistant Tuberculosis Poses a Major Challenge to Global TB Control Efforts?
3. Hotspots of Drug-resistant Tuberculosis as Key Drivers of Epidemic Intelligence for Public Health Action
4. Antibiotic Resistance Factors in Multidrug-resistant Tuberculosis
5. Trends in Multidrug-resistant Tuberculosis
6. Barriers in the Development of Specific Drug Susceptibility Testing
Section 2: Diagnostic
7. Decoding Resistance: Role of Mutations in Tuberculosis Treatment Failure
8. Early Detection Tools of Pulmonary Tuberculosis Affecting Treatment Outcome
9. How One Can Lead to Extensively Drug-resistant Tuberculosis?
10. Strain Typing Methods in the Identification of Drug Resistance in Mycobacterium Tuberculosis
11. Pattern and Characteristics of Mutation in Drug-resistant Clinical Isolates of Extrapulmonary Tuberculosis
12. Impact of Genome Sequencing on Multidrug-resistant Tuberculosis Diagnosis and Prevalence
13. Current Advances and Persistent Challenges in the Treatment of Pediatric Drug-resistant Tuberculosis
Section 3: Clinical
14. Closing the Gap between Evidence and Implementation in Multidrug-resistant Tuberculosis Management
15. Significance of Inappropriate or Interrupted Treatment in Tuberculosis
16. Nonadherence to Medication Regimens: Impact on Drug Resistance
17. Strategies to Prevent Mortality and Severe Illness in Multidrug-resistant Tuberculosis
18. Therapeutic Drugs Monitoring in Multidrug-resistant Treatment
Section 4: Treatment
19. Phytochemicals to Combat Multidrug-resistant Tuberculosis
20. Revolutionizing Drug-resistant Tuberculosis Care: The Global BPaL Implementation Experience
21. Poor Drug Quality: Impact on Drug Resistance
22. Surgical Modalities in Multidrug-resistant/Extensively Drug-resistant Tuberculosis
23. Recent Advances in Management of Drug-resistant Tuberculosis
24. Global Drug Pipeline for Tuberculosis Treatment
25. Current Regimens for Drug-resistant Tuberculosis
26. Challenges in Early Detection, Management and Prevention of Multidrug-resistant Tuberculosis in Geriatric Patients
Section 5: Associated Diseases
27. Multidrug-resistant Tuberculosis during Pregnancy
28. Molecular Changes in Diabetes and Multidrug-resistant Tuberculosis
29. Psychiatric Disorders in Drug-resistant Tuberculosis
30. Antimicrobial Resistance Fight: Preventing Drug Resistance
31. Mitigating Strategies to Prevent Drug Resistance
32. Airborne Transmission of Drug-resistant Tuberculosis
33. Problematic Issues in Implementation of Drug-resistant Tuberculosis Case Management
Section 6: Prevention
34. Multidrug Resistance in Tuberculosis: Contact Tracing and Isolation of Infected Individuals
35. Multidrug-resistant Tuberculosis: Infection Prevention and Control Measures in Healthcare Settings
36. Importance of Prevention, Early Diagnosis and Adherence to Treatment: Latent and Subclinical TB
37. Novel Tuberculosis Vaccines: A Promising Approach for Multidrug-resistant Tuberculosis Elimination
Section 7: Newer Initiatives
38. Role of Artificial Intelligence in Tuberculosis
39. Artificial Intelligence in Managing Drug Adherence
40. Role of DNA Fingerprinting in Multidrug-resistant Tuberculosis
41. Epigenetic Regulation of Drug Resistance in Tuberculosis
42. Functional Analysis of Toxin-antitoxin System in Multidrug-resistant Tuberculosis
43. Phenotypic Drug Resistance: An Update in Pediatric Tuberculosis
VK Arora Diploma in Chest Diseases (DCD) MD (Tuberculosis and Respiratory Diseases/Medicine) MBBS
Tuberculous and Chest Diseases Specialist; Chairman, TB Association of India; Executive Editor of Indian Journal of Tuberculosis, New Delhi, India
Kamal Chopra MBBS MD (Chest and TB) DTCE (Diploma in TB Control and Eradication) Tokyo
Consultant and Former Director, New Delhi Tuberculosis Centre; Academic Editor, PLoS One; Associate Executive Editor of Indian Journal of Tuberculosis, New Delhi, India
"About this title" may belong to another edition of this title.
All Returns and Refund are as per Abebooks policies.
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to Ria Christie Collections, Uxbridge, United Kingdom, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
Orders usually ship within 2 business days. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required. Thank you!
| Order quantity | 6 to 12 business days | 6 to 12 business days |
|---|---|---|
| First item | £ 11.98 | £ 11.98 |
Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.